Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients
- PMID: 3066087
- DOI: 10.1007/BF02581372
Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients
Abstract
Pancreatic B-cell function in relation to diabetic retinopathy was studied in 195 NIDDM patients with long-standing diabetes. Background diabetic retinopathy (BDR) was present in 95 (48.7%) and proliferative retinopathy (PDR) in 17 (8.7%) of the subjects. There was no significant difference between the BDR, PDR, and non-retinopathy groups with respect to age, age at diagnosis of diabetes and HbA1 values. Mean duration of diabetes was higher in the PDR group (p less than 0.05). Serum C-peptide values showed no correlation with the presence of retinopathy or with the duration of diabetes. The C-peptide values were widely scattered in patients with BDR and PDR showing no association between pancreatic B-cell reserve and occurrence or severity of retinopathy in NIDDM patients. Thus, decreased pancreatic B-cell reserve does not appear to be a risk factor for diabetic retinopathy in NIDDM patients.
Similar articles
-
Development and progression of diabetic retinopathy in Koreans with NIDDM.Diabetes Care. 1998 Jan;21(1):134-8. doi: 10.2337/diacare.21.1.134. Diabetes Care. 1998. PMID: 9538984
-
High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.Diabetes Care. 1998 Dec;21(12):2149-51. doi: 10.2337/diacare.21.12.2149. Diabetes Care. 1998. PMID: 9839109
-
Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese Type 2 diabetes.J Diabetes Complications. 2000 Sep-Oct;14(5):281-7. doi: 10.1016/s1056-8727(00)00114-8. J Diabetes Complications. 2000. PMID: 11113692
-
High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity.Diabetes Res Clin Pract. 1989 Jan 3;6(1):45-52. doi: 10.1016/0168-8227(89)90056-9. Diabetes Res Clin Pract. 1989. PMID: 2649341
-
Epidemiology of proliferative diabetic retinopathy.Diabetes Care. 1992 Dec;15(12):1875-91. doi: 10.2337/diacare.15.12.1875. Diabetes Care. 1992. PMID: 1464243 Review.
Cited by
-
The average 30-minute post-prandial C-peptide predicted diabetic retinopathy progress: a retro-prospective study.BMC Endocr Disord. 2023 Mar 16;23(1):63. doi: 10.1186/s12902-023-01300-x. BMC Endocr Disord. 2023. PMID: 36922809 Free PMC article.
-
Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness.Front Endocrinol (Lausanne). 2021 Nov 29;12:734360. doi: 10.3389/fendo.2021.734360. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34912295 Free PMC article.
-
Relationship between C peptide and chronic complications in type-2 diabetes mellitus.J Natl Med Assoc. 2005 Aug;97(8):1113-8. J Natl Med Assoc. 2005. PMID: 16173326 Free PMC article.
-
Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes.BMJ Open Diabetes Res Care. 2014 Oct 24;2(1):e000027. doi: 10.1136/bmjdrc-2014-000027. eCollection 2014. BMJ Open Diabetes Res Care. 2014. PMID: 25452868 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous